Trials / Unknown
UnknownNCT00255554
DBT and Escitalopram in Borderline Personality Disorder
Effects of Dialectical Behavioral Therapy and Escitalopram on Impulsive Aggression, Affective Instability and Cognitive Processing in Borderline Personality Disorder
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Bronx VA Medical Center · Federal
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Subjects will receive six months of DBT, consisting of one 90-minute group and one 60-minute individual session per week as well as telephone availability of the individual therapist. Half the subjects will concurrently receive escitalopram while half will receive placebo, in a randomized double-blind design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Dialectical Behavioral Therapy | |
| DRUG | Escitalopram |
Timeline
- First posted
- 2005-11-21
- Last updated
- 2005-11-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00255554. Inclusion in this directory is not an endorsement.